Michael R. Hamblin

Nanotheragnosis: an emerging frontier review in personalized cancer medicine.

Cancer remains a major cause of global mortality, while late-stage diagnosis and therapeutic resistance highlight the need for individualized strategies. Nanotheranostics has emerged as a promising paradigm by integrating cancer diagnosis and treatment within multifunctional nanosystems. However, most current approache...